Pharmaceuticals 2013, 6(11), 1361-1380; doi:10.3390/ph6111361
Review

Nanoparticles as Drug Delivery Systems in Cancer Medicine: Emphasis on RNAi-Containing Nanoliposomes

1 Department of Biochemistry, University of Puerto Rico, San Juan, Puerto Rico 00935, USA 2 Comprehensive Cancer Center & Department of Biochemistry, University of Puerto Rico, San Juan, Puerto Rico 00935, USA
* Author to whom correspondence should be addressed.
Received: 12 September 2013; in revised form: 24 October 2013 / Accepted: 28 October 2013 / Published: 4 November 2013
(This article belongs to the Special Issue Chemotherapeutic Agents)
PDF Full-text Download PDF Full-Text [468 KB, uploaded 4 November 2013 14:55 CET]
Abstract: Nanomedicine is a growing research field dealing with the creation and manipulation of materials at a nanometer scale for the better treatment, diagnosis and imaging of diseases. In cancer medicine, the use of nanoparticles as drug delivery systems has advanced the bioavailability, in vivo stability, intestinal absorption, solubility, sustained and targeted delivery, and therapeutic effectiveness of several anticancer agents. The expansion of novel nanoparticles for drug delivery is an exciting and challenging research filed, in particular for the delivery of emerging cancer therapies, including small interference RNA (siRNA) and microRNA (miRNAs)-based molecules. In this review, we focus on the currently available drug delivery systems for anticancer agents. In addition, we will discuss the promising use of nanoparticles for novel cancer treatment strategies.
Keywords: nanoparticles; nanoliposomes; RNAi; miRNA; siRNA

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Díaz, M.R.; Vivas-Mejia, P.E. Nanoparticles as Drug Delivery Systems in Cancer Medicine: Emphasis on RNAi-Containing Nanoliposomes. Pharmaceuticals 2013, 6, 1361-1380.

AMA Style

Díaz MR, Vivas-Mejia PE. Nanoparticles as Drug Delivery Systems in Cancer Medicine: Emphasis on RNAi-Containing Nanoliposomes. Pharmaceuticals. 2013; 6(11):1361-1380.

Chicago/Turabian Style

Díaz, Mónica R.; Vivas-Mejia, Pablo E. 2013. "Nanoparticles as Drug Delivery Systems in Cancer Medicine: Emphasis on RNAi-Containing Nanoliposomes." Pharmaceuticals 6, no. 11: 1361-1380.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert